Zubrin
Withdrawn
tepoxalin
MedicineVeterinaryWithdrawn
The market authorisation for Zubrin has been withdrawn at the request of the marketing-authorisation holder.
Reduction of inflammation and relief of pain caused by acute and chronic musculoskeletal disorders.